发明名称 Dissolution composition for examining drug solubility
摘要 There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media that simulate the composition of the intestinal fluids in fasted and fed states.
申请公布号 US8889189(B2) 申请公布日期 2014.11.18
申请号 US201213652837 申请日期 2012.10.16
申请人 Phares Pharmaceutical Research, N.V. 发明人 Leigh Steve;Leigh Mathew Louis Steven;Van Hoogevest Peter;Streich Daniel;Quinton Jacques
分类号 A61K9/14;A61K9/08;A61K9/10;A61K47/12;A61K47/44;G01N33/15 主分类号 A61K9/14
代理机构 Morriss O'Bryant Compagni, PC 代理人 Morriss O'Bryant Compagni, PC
主权项 1. A method of determining solubility or dissolution of a pharmacological compound, comprising: preparing an aqueous medium containing at least one buffer component and at least one osmotic agent; adding a homogeneous solid dissolution composition in a granular or powder form comprising at least one bile salt and at least one phospholipid to the aqueous medium to form a simulated gastrointestinal medium; adding at least one of a pharmacological compound, a physiological compound and a dosage form to the simulated gastrointestinal medium to determine a solubility or dissolution characteristic of the pharmacological compound, physiological compound or dosage form.
地址 NL